Christine Bourke

Dr. Christine Bourke

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CBChristine Bourke
Christine Bourke
BCBrendan Kyle Cummings
Brendan Kyle Cummings
DHDaire Hurley
Daire Hurley
CMConor C. Murphy
Conor C. Murphy
SCSarah Chamney
Sarah Chamney
Stevens–Johnson syndrome (SJS) and the more severe variant, toxic epidermal necrolysis (TEN), are a spectrum of mucocutaneous reactions with potentially devastating ocular consequences. Ocular complications occur in about 70% of patients with Stevens–Johnson syndrome, and 35% continue with chronic disease. We report an unusual presentation of isolated ocular Stevens–Johnson syndrome in a patient with recently diagnosed ulcerative colitis being treated with Infliximab. The case had an insidious and atypical onset and represented a diagnostic dilemma. The diagnosis was more difficult, due to the fact that the inciting agent had long been stopped. Severe bacterial conjunctivitis such as that caused by Chlamydia Trachomatis, Corynebacterium diphtheria, and Neisseria Gonorrhea can cause forniceal shortening and symblepharon; this diagnosis was ruled out with microbiological swabs. A conjunctival biopsy was the key to diagnosis. Treatment involved high-dose IV steroids and dual immunosuppression with Infliximab and mycophenolate mofetil. We sought to employ interventions with the greatest impacts on our patient’s condition. Our experience contributes to the growing evidence supporting intensive ophthalmic management of SJS to prevent long-term vision loss.

31 July 2025 in Journal of American Association for Pediatric Ophthalmology and Strabismus
Verified
Journal Article
Closed access
CBChristine Bourke
Christine Bourke
VPVasiliki Panteli
Vasiliki Panteli
OMOliver R. Marmoy
Oliver R. Marmoy
DTDorothy A. Thompson
Dorothy A. Thompson
KMKshitij Mankad
Kshitij Mankad
RBRichard Bowman
Richard Bowman

29 June 2025 in Ophthalmic Genetics
Verified
Journal Article
Closed access
CBChristine Bourke
Christine Bourke
DTD.A. Thompson
D.A. Thompson
MMM. Moosajee
M. Moosajee
ILI.C. Lloyd
I.C. Lloyd
To describe previously unreported ocular manifestations associated with a de novo PAX2 variant and emphasise their diagnostic significance in PAX2 related disorder. A two month old boy underwent comprehensive ocular assessment (cycloplegic refraction, slit lamp biomicroscopy, axial length, and fundus imaging), full field and multifocal electroretinography, high resolution orbital MRI, and renal ultrasonography. Trio whole genome sequencing (WGS) was performed to identify pathogenic variants. Ophthalmic evaluation revealed asymmetric microcornea (9.5 mm OD, 10.8 mm OS), microphthalmos (axial length 17.1 mm OD, 18.4 mm OS), anterior segment dysgenesis with shallow anterior chambers, and high myopia (12.50 D OD, 10.75 D OS). Fundus photography demonstrated bilateral, steeply excavated optic discs bordered by circumferential peripapillary retinal pigment epithelium agenesis. Multifocal ERG showed markedly reduced central responses, consistent with bilateral macular pathway dysfunction; full field ERG was otherwise within age matched limits. Orbital MRI confirmed fusiform enlargement of the intra orbital optic nerves and colobomatous optic nerve head defects, with anomalous infra orbital optic nerve sheaths. Renal ultrasound was normal. Trio WGS identified a de novo heterozygous PAX2 frameshift variant, c.76dup p.(Val26GlyfsTer28), classified as pathogenic (ACMG criteria PVS1, PS2). This case expands the phenotypic spectrum of PAX2 related disorder to include anterior segment dysgenesis, axial myopia, peripapillary RPE agenesis, and abnormal infra orbital optic nerve sheaths in the absence of renal hypodysplasia. Recognition of these atypical ocular findings should prompt targeted genetic testing for PAX2, facilitating accurate diagnosis, anticipatory renal surveillance, and informed genetic counselling.

11 December 2025 in International Journal of Health Care Quality Assurance
Verified
Journal Article
Closed access
CBChristine Bourke
Christine Bourke
AMAaron Mullaniff
Aaron Mullaniff
BTBobby Tang
Bobby Tang
OWOriyomi Waya
Oriyomi Waya
Seán Paul TeelingSeán Paul Teeling
Seán Paul Teeling
Purpose: Process improvement methodologies such as Lean Six Sigma are increasingly being deployed to address inefficiencies in healthcare. Simultaneously, global policy and strategy development stress the value of person-centredness in healthcare. This paper examines the application of a Person-Centred Lean Six Sigma Model (PCLSSM) to improve processes in a paediatric eye care clinic, specifically focusing on streamlining the referral system and optimising the clinic environment. Design/methodology/approach: A quasi-experimental, single-site, pretest–posttest study was conducted over nine months using the Lean Six Sigma define, measure, analyse, improve and control (DMAIC) framework. Data were gathered through Voice of the Customer (VOC) sessions, Gemba observations, process mapping and referral letter audits. Key stakeholders, including clinicians, administrative staff and parents, co-designed the interventions to enhance efficiency and patient experience. Findings: The application of the PCLSSM resulted in a 46% increase in right-first-time referral accuracy, a 20% reduction in referral processing time, a 13% increase in staff confidence in the referral system, a 158% improvement in staff satisfaction with workload and a 104% rise in child and parent satisfaction with their clinic experience. The implementation of an electronic referral system and an improved clinic environment contributed to these improvements. Originality/value: This study is the first to integrate a person-centred approach with Lean Six Sigma in paediatric ophthalmology. The findings demonstrate the potential of combining process improvement methodologies with person-centred principles to enhance operational efficiency and stakeholder satisfaction. This approach can serve as a model for similar outpatient settings seeking to improve service delivery and patient experience.